Long term survival in a patient with recurrent metastatic Ewing sarcoma treated with irinotecan and temozolomide
Ewing sarcoma family of tumor is the second most common bone tumor in children and young adults, after osteosarcoma. Different chemotherapeutic regimens are used in treatment of relapsed/recurrent Ewing sarcoma. Promising results were achieved with combination of irinotecan and temozolomide. Our cas...
Main Authors: | Hakan Gelincik, Serhan Kupeli |
---|---|
Format: | Article |
Language: | English |
Published: |
Cukurova University
2016-12-01
|
Series: | Çukurova Üniversitesi Tıp Fakültesi Dergisi |
Subjects: | |
Online Access: | http://www.scopemed.org/fulltextpdf.php?mno=227350 |
Similar Items
-
Front-Line Window Therapy with Temozolomide and Irinotecan in Patients with Primary Disseminated Multifocal Ewing Sarcoma: Results of the ISG/AIEOP EW-2 Study
by: Sebastian Dorin Asaftei, et al.
Published: (2021-06-01) -
Nanoformulation of Talazoparib Increases Maximum Tolerated Doses in Combination With Temozolomide for Treatment of Ewing Sarcoma
by: Paige Baldwin, et al.
Published: (2019-12-01) -
Bevacizumab, irinotecan, and temozolomide with re-irradiation in adult recurrent medulloblastoma: A first case report
by: Takahiro Yamauchi, et al.
Published: (2021-09-01) -
Management of recurrent Ewing sarcoma: challenges and approaches
by: Van Mater D, et al.
Published: (2019-03-01) -
An Unusual Cause of Urinary Incontinence: Ewing's Sarcoma
by: Serhan Kupeli
Published: (2015-03-01)